SlideShare uma empresa Scribd logo
1 de 1
Baixar para ler offline
1188			 BMJ | 22 NOVEMBER 2008 | Volume 337
principalresultsofthehypertensionoptimaltreatment
(HOT)randomisedtrial.Lancet1998;351:1755-62.
PulmonaryEmbolismPrevention(PEP)TrialCollaborative5	
Group. Prevention of pulmonary embolism and
deep vein thrombosis with low dose aspirin:
Pulmonary Embolism Prevention (PEP) trial. Lancet
2000;355:1295-302.
Citethisas:BMJ2008;337:a2583
Shared electronic records
What have we really learnt?
Greenhalgh and colleagues see the shared
electronic record as having to respond to existing
ways of working and established practices, not
the other way round.1
My take is this:
Powerful forces in established ways of working•  
in the NHS are hostile to technological
changes that threaten established and
possibly dysfunctional and wasteful practices.
As a taxpayer, this is not acceptable,
especially when we need to explore better
ways of using tax revenues when times are
likely to be hard
The scale of complex IT projects empowers•  
dissident critics to feed political interest in
their failings. That these projects frequently
focus on purely internal (to the NHS) goals
and objectives makes them largely inscrutable
with respect to benefits that may accrue to
patients and their failure more damaging
as there are no milestones for delivering
taxpayer value. It is better to thinkof flexible,
networked, and distributed approaches—a
school of fish adjusting easily to changes in
its environment versus a supertanker that is
much harder to control. Politicians would be
better responding to the benefits that large
scale IT projects bring to the public than to
internal NHS efficiencies that may result
Introducing new technologies must have•  
some consequences, and these are not
necessarily helped by protecting incumbents
and legacy systems from threat.
The lackof a patient held smart card for
health, for instance, maintains the control of
information in the hands of the clinicians and
the provider infrastructure. Giving patients
complete and total ownership of their health
record is a critical way of driving quality
improvement.
My fear is that the sunkcosts are already
so great that a rethinkis unthinkable and that
we cannot cut our losses and start again. In
politics this would be a U turn, requiring another
innovation called courage.
MichaelTremblayhealthtechnologyandinnovationpolicy
adviser,BrabourneLees,Ashford,KentTN256RJ
mike@tremblay-consulting.biz
Competinginterests:Nonedeclared.
GreenhalghT,StramerK,BratanT,ByrneE,MohammadY,1	
RussellJ.Introductionofsharedelectronicrecords:multi-
sitecasestudyusingdiffusionofinnovationtheory.BMJ
2008;337:a1786.(23October.)
Citethisas:BMJ2008;337:a2595
DisruptivenessofGoogleHealth
Such is the pace of modern technology that the
paper by Greenhalgh and colleagues is already
out of date.1
They did not mention the launch of
Google’s web based personal health record on
20 May 2008 or the collapse of the NHSrecords
system.2
Web 2.0 technology will no doubt disrupt the
grand aspirations of the NHSIT project.Techno-
savvy patients using Google style applications
might soon askdoctors to access their personal
health records on the web.
Like the music industry, the NHSseems to
have become self importantly complacent. We
are deluding ourselves if we thinkthat “the world
is waiting to see” how the NHSIT programme
unfolds.The world has already seen that, six
years into the programme, NPfIT is overbudget
and behind schedule.The NHSisn’t the global
gold standard. Instead, it is a hugely wasteful,
inefficient, and bloated monopoly that needs
some serious competition. Did record companies
ever imagine that one day music could be
downloaded for free?
SuparnaDaslocumconsultantanaesthetist,King’sCollege
Hospital,LondonSE59RSsuparna.das@btinternet.com
Competinginterests:Nonedeclared.
GreenhalghT,StramerK,BratanT,ByrneE,MohammadY,1	
RussellJ.Introductionofsharedelectronicrecords:multi-
sitecasestudyusingdiffusionofinnovationtheory.BMJ
2008;337:a1786.(23October.)
TimminsN.NHSrecordsprojectgrindstohalt.2	 Financial
Times2008Oct27:23.www.ft.com/cms/s/0/b54a2e1c-
a46e-11dd-8104-000077b07658.html
Citethisas:BMJ2008;337:a2596
Mandatory flu vaccination
Patient care drives mandatory
vaccination
Both sidesdebating mandatoryfluvaccination
for healthcare workerscanvasscentral
arguments,1 2
butkeyissuesrequire further
exploration. Neither side acknowledged
thathealth care differsfundamentallyfrom
other work. Itsprimaryaim isnotindividual
protection butprotection ofpatientsbyreducing
nosocomialflu. JohnStuartMillswould support,
notoppose, a mandatoryprogramme.2
The autonomyargumentfocuseson individual
rightsofhealthcare workers, ignoring the rightsof
others. Ethicalassessmentrequiresusto balance
competing rights, and should include a patient’s
rightto a safe healthcare environment. Australian
StatesandTerritoriesalreadyrequire hepatitisB
vaccination for those who are notimmune and
provide patientcare. Individualautonomyisnot
catered for, with healthcare workersexercising
their rightto choose more fundamentally: either
workin health care and minimise the riskof
infecting patientsor workelsewhere.
Increasing fluvaccine coverage among
healthcare workersispossible using incentives
and signed declination, butresultsare better1
and costlessto implementwith mandatory
requirements. Better coverage ata lower price
makesa mandatoryprogramme dominantin
health economictermsbefore consideration of
improved outcomes.
Mostdeveloped industrialised countrieshave
workplace health and safetylawsthatrequire
workersto be “free from riskofdeath, injury
or illnesscaused byanyworkplace.”3
Flu isan
annualand predictable workplace danger that
universalvaccination ofhealthcare workerscan
reduce. How can mandatoryprogrammesnotbe
required under such laws?
Given thatvaccinating eighthealthcare
workerscan preventthe death ofone patient,4
how can healthcare workerscontinue to oppose
mandatoryfluvaccination?
StephenBLambertmedicalepidemiologist,Queensland
PaediatricInfectiousDiseasesLaboratory,RoyalChildren’s
Hospital,Herston,QLD4029,Australiasblambert@uq.edu.au
Competinginterests:SBLhasbeenaninvestigatoronindustry
sponsoredvaccinestudies,receivedatravelgranttoattenda
conference,andbeenamemberofvaccineadvisoryboardsfor
GSKandNovartis.
HelmsCM,PolgreenPM.Shouldinfluenzaimmunisation1	
bemandatoryforhealthcareworkers?Yes.BMJ
2008;337:a2142.(28October.)
IsaacsD,LeaskJ.Shouldinfluenzaimmunisation2	
bemandatoryforhealthcareworkers?No.BMJ
2008;337:a2140.(28October.)
WorkplaceHealthSafetyAct1995(QLD).s22.www.3	
legislation.qld.gov.au/LEGISLTN/CURRENT/W/
WorkplHSaA95.pdf
HaywardAC,HarlingR,WettenS,JohnsonAM,Munro4	
S,SmedleyJ,etal.Effectivenessofaninfluenzavaccine
programmeforcarehomestafftopreventdeath,
morbidity,andhealthserviceuseamongresidents:
clusterrandomisedcontrolledtrial.BMJ2006;333:1241.
Citethisas:BMJ2008;337:a2588
Addressing doctors
Scandinavian solution
I recently started work in Sweden after a UK
medical education and several years working in
the NHS.
I find the Swedish solution of introductions
very appealing: completely do away with titles
and address everyone by their first and second
names.1
So my badge says “Alison Godbolt,
doctor,” and that’s how I introduce myself.
Alison K Godbolt specialist trainee in rehabilitation medicine,
Uppsala University Hospital, Uppsala, Sweden
alison.godbolt@neuro.uu.se
Competing interests: None declared.
Spence D. You can call me Des.1	 BMJ 2008;337:a2328.
(29 October.)
Citethisas:BMJ2008;337:a2586

Mais conteúdo relacionado

Semelhante a Disruptiveness of Google Health

19The Complexity and Evolving Technolog.docx
19The Complexity and Evolving Technolog.docx19The Complexity and Evolving Technolog.docx
19The Complexity and Evolving Technolog.docxdurantheseldine
 
Digital Therapeutics: Augmenting patient health outcomes
Digital Therapeutics: Augmenting patient health outcomesDigital Therapeutics: Augmenting patient health outcomes
Digital Therapeutics: Augmenting patient health outcomespoojatmr
 
New Access Models for Healthcare
New Access Models for HealthcareNew Access Models for Healthcare
New Access Models for HealthcareTyrone Grandison
 
ESMO-2022-Reck-Presentation_0.pptx
ESMO-2022-Reck-Presentation_0.pptxESMO-2022-Reck-Presentation_0.pptx
ESMO-2022-Reck-Presentation_0.pptxMrc Mrc
 
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...Tauseef Naquishbandi
 
Healthcare Effectiveness - Technological stepping stones to confront healthca...
Healthcare Effectiveness - Technological stepping stones to confront healthca...Healthcare Effectiveness - Technological stepping stones to confront healthca...
Healthcare Effectiveness - Technological stepping stones to confront healthca...NEORIS
 
Improving health care outcomes with responsible data science #escience2018
Improving health care outcomes with responsible data science #escience2018Improving health care outcomes with responsible data science #escience2018
Improving health care outcomes with responsible data science #escience2018Wessel Kraaij
 
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”IJAEMSJORNAL
 
Innovation In Medical Care
Innovation In Medical CareInnovation In Medical Care
Innovation In Medical Caresirlkm
 
Clinical Data Science and its Future
Clinical Data Science and its FutureClinical Data Science and its Future
Clinical Data Science and its FutureEditorIJTSRD1
 
Determining the Factors of Slow Adoption of Information and Communication Tec...
Determining the Factors of Slow Adoption of Information and Communication Tec...Determining the Factors of Slow Adoption of Information and Communication Tec...
Determining the Factors of Slow Adoption of Information and Communication Tec...Jasfia Khanam Fama
 
TECHNOLOGYVENTURES-SYNTHESISREPORT
TECHNOLOGYVENTURES-SYNTHESISREPORTTECHNOLOGYVENTURES-SYNTHESISREPORT
TECHNOLOGYVENTURES-SYNTHESISREPORTAngel Salazar
 
16072 emc-healthcare idc-ebook-1.27
16072 emc-healthcare idc-ebook-1.2716072 emc-healthcare idc-ebook-1.27
16072 emc-healthcare idc-ebook-1.27Simona Vellani
 
16072-EMC-HealthcareIDC-eBook-1.27
16072-EMC-HealthcareIDC-eBook-1.2716072-EMC-HealthcareIDC-eBook-1.27
16072-EMC-HealthcareIDC-eBook-1.27Simona Vellani
 
A Significant Gap In The NBN Corporate Plan
A Significant Gap In The NBN Corporate PlanA Significant Gap In The NBN Corporate Plan
A Significant Gap In The NBN Corporate PlanGina Brown
 
Acus intel medical_devices
Acus intel medical_devicesAcus intel medical_devices
Acus intel medical_devicesatlanticcouncil
 

Semelhante a Disruptiveness of Google Health (20)

19The Complexity and Evolving Technolog.docx
19The Complexity and Evolving Technolog.docx19The Complexity and Evolving Technolog.docx
19The Complexity and Evolving Technolog.docx
 
Digital Therapeutics: Augmenting patient health outcomes
Digital Therapeutics: Augmenting patient health outcomesDigital Therapeutics: Augmenting patient health outcomes
Digital Therapeutics: Augmenting patient health outcomes
 
New Access Models for Healthcare
New Access Models for HealthcareNew Access Models for Healthcare
New Access Models for Healthcare
 
The viability of technology-based smoking cessation programs in developing co...
The viability of technology-based smoking cessation programs in developing co...The viability of technology-based smoking cessation programs in developing co...
The viability of technology-based smoking cessation programs in developing co...
 
ESMO-2022-Reck-Presentation_0.pptx
ESMO-2022-Reck-Presentation_0.pptxESMO-2022-Reck-Presentation_0.pptx
ESMO-2022-Reck-Presentation_0.pptx
 
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...
Big Data, CEP and IoT : Redefining Holistic Healthcare Information Systems an...
 
Healthcare Effectiveness - Technological stepping stones to confront healthca...
Healthcare Effectiveness - Technological stepping stones to confront healthca...Healthcare Effectiveness - Technological stepping stones to confront healthca...
Healthcare Effectiveness - Technological stepping stones to confront healthca...
 
Improving health care outcomes with responsible data science #escience2018
Improving health care outcomes with responsible data science #escience2018Improving health care outcomes with responsible data science #escience2018
Improving health care outcomes with responsible data science #escience2018
 
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”
 
0207 2 Jan Geissler - Hot topics in oncology big data
0207 2 Jan Geissler - Hot topics in oncology big data0207 2 Jan Geissler - Hot topics in oncology big data
0207 2 Jan Geissler - Hot topics in oncology big data
 
Innovation In Medical Care
Innovation In Medical CareInnovation In Medical Care
Innovation In Medical Care
 
Clinical Data Science and its Future
Clinical Data Science and its FutureClinical Data Science and its Future
Clinical Data Science and its Future
 
Determining the Factors of Slow Adoption of Information and Communication Tec...
Determining the Factors of Slow Adoption of Information and Communication Tec...Determining the Factors of Slow Adoption of Information and Communication Tec...
Determining the Factors of Slow Adoption of Information and Communication Tec...
 
TECHNOLOGYVENTURES-SYNTHESISREPORT
TECHNOLOGYVENTURES-SYNTHESISREPORTTECHNOLOGYVENTURES-SYNTHESISREPORT
TECHNOLOGYVENTURES-SYNTHESISREPORT
 
16072 emc-healthcare idc-ebook-1.27
16072 emc-healthcare idc-ebook-1.2716072 emc-healthcare idc-ebook-1.27
16072 emc-healthcare idc-ebook-1.27
 
16072-EMC-HealthcareIDC-eBook-1.27
16072-EMC-HealthcareIDC-eBook-1.2716072-EMC-HealthcareIDC-eBook-1.27
16072-EMC-HealthcareIDC-eBook-1.27
 
Keys of excellence in research
Keys of excellence in researchKeys of excellence in research
Keys of excellence in research
 
Megatrends
MegatrendsMegatrends
Megatrends
 
A Significant Gap In The NBN Corporate Plan
A Significant Gap In The NBN Corporate PlanA Significant Gap In The NBN Corporate Plan
A Significant Gap In The NBN Corporate Plan
 
Acus intel medical_devices
Acus intel medical_devicesAcus intel medical_devices
Acus intel medical_devices
 

Último

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 

Último (20)

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 

Disruptiveness of Google Health

  • 1. 1188 BMJ | 22 NOVEMBER 2008 | Volume 337 principalresultsofthehypertensionoptimaltreatment (HOT)randomisedtrial.Lancet1998;351:1755-62. PulmonaryEmbolismPrevention(PEP)TrialCollaborative5 Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302. Citethisas:BMJ2008;337:a2583 Shared electronic records What have we really learnt? Greenhalgh and colleagues see the shared electronic record as having to respond to existing ways of working and established practices, not the other way round.1 My take is this: Powerful forces in established ways of working•   in the NHS are hostile to technological changes that threaten established and possibly dysfunctional and wasteful practices. As a taxpayer, this is not acceptable, especially when we need to explore better ways of using tax revenues when times are likely to be hard The scale of complex IT projects empowers•   dissident critics to feed political interest in their failings. That these projects frequently focus on purely internal (to the NHS) goals and objectives makes them largely inscrutable with respect to benefits that may accrue to patients and their failure more damaging as there are no milestones for delivering taxpayer value. It is better to thinkof flexible, networked, and distributed approaches—a school of fish adjusting easily to changes in its environment versus a supertanker that is much harder to control. Politicians would be better responding to the benefits that large scale IT projects bring to the public than to internal NHS efficiencies that may result Introducing new technologies must have•   some consequences, and these are not necessarily helped by protecting incumbents and legacy systems from threat. The lackof a patient held smart card for health, for instance, maintains the control of information in the hands of the clinicians and the provider infrastructure. Giving patients complete and total ownership of their health record is a critical way of driving quality improvement. My fear is that the sunkcosts are already so great that a rethinkis unthinkable and that we cannot cut our losses and start again. In politics this would be a U turn, requiring another innovation called courage. MichaelTremblayhealthtechnologyandinnovationpolicy adviser,BrabourneLees,Ashford,KentTN256RJ mike@tremblay-consulting.biz Competinginterests:Nonedeclared. GreenhalghT,StramerK,BratanT,ByrneE,MohammadY,1 RussellJ.Introductionofsharedelectronicrecords:multi- sitecasestudyusingdiffusionofinnovationtheory.BMJ 2008;337:a1786.(23October.) Citethisas:BMJ2008;337:a2595 DisruptivenessofGoogleHealth Such is the pace of modern technology that the paper by Greenhalgh and colleagues is already out of date.1 They did not mention the launch of Google’s web based personal health record on 20 May 2008 or the collapse of the NHSrecords system.2 Web 2.0 technology will no doubt disrupt the grand aspirations of the NHSIT project.Techno- savvy patients using Google style applications might soon askdoctors to access their personal health records on the web. Like the music industry, the NHSseems to have become self importantly complacent. We are deluding ourselves if we thinkthat “the world is waiting to see” how the NHSIT programme unfolds.The world has already seen that, six years into the programme, NPfIT is overbudget and behind schedule.The NHSisn’t the global gold standard. Instead, it is a hugely wasteful, inefficient, and bloated monopoly that needs some serious competition. Did record companies ever imagine that one day music could be downloaded for free? SuparnaDaslocumconsultantanaesthetist,King’sCollege Hospital,LondonSE59RSsuparna.das@btinternet.com Competinginterests:Nonedeclared. GreenhalghT,StramerK,BratanT,ByrneE,MohammadY,1 RussellJ.Introductionofsharedelectronicrecords:multi- sitecasestudyusingdiffusionofinnovationtheory.BMJ 2008;337:a1786.(23October.) TimminsN.NHSrecordsprojectgrindstohalt.2 Financial Times2008Oct27:23.www.ft.com/cms/s/0/b54a2e1c- a46e-11dd-8104-000077b07658.html Citethisas:BMJ2008;337:a2596 Mandatory flu vaccination Patient care drives mandatory vaccination Both sidesdebating mandatoryfluvaccination for healthcare workerscanvasscentral arguments,1 2 butkeyissuesrequire further exploration. Neither side acknowledged thathealth care differsfundamentallyfrom other work. Itsprimaryaim isnotindividual protection butprotection ofpatientsbyreducing nosocomialflu. JohnStuartMillswould support, notoppose, a mandatoryprogramme.2 The autonomyargumentfocuseson individual rightsofhealthcare workers, ignoring the rightsof others. Ethicalassessmentrequiresusto balance competing rights, and should include a patient’s rightto a safe healthcare environment. Australian StatesandTerritoriesalreadyrequire hepatitisB vaccination for those who are notimmune and provide patientcare. Individualautonomyisnot catered for, with healthcare workersexercising their rightto choose more fundamentally: either workin health care and minimise the riskof infecting patientsor workelsewhere. Increasing fluvaccine coverage among healthcare workersispossible using incentives and signed declination, butresultsare better1 and costlessto implementwith mandatory requirements. Better coverage ata lower price makesa mandatoryprogramme dominantin health economictermsbefore consideration of improved outcomes. Mostdeveloped industrialised countrieshave workplace health and safetylawsthatrequire workersto be “free from riskofdeath, injury or illnesscaused byanyworkplace.”3 Flu isan annualand predictable workplace danger that universalvaccination ofhealthcare workerscan reduce. How can mandatoryprogrammesnotbe required under such laws? Given thatvaccinating eighthealthcare workerscan preventthe death ofone patient,4 how can healthcare workerscontinue to oppose mandatoryfluvaccination? StephenBLambertmedicalepidemiologist,Queensland PaediatricInfectiousDiseasesLaboratory,RoyalChildren’s Hospital,Herston,QLD4029,Australiasblambert@uq.edu.au Competinginterests:SBLhasbeenaninvestigatoronindustry sponsoredvaccinestudies,receivedatravelgranttoattenda conference,andbeenamemberofvaccineadvisoryboardsfor GSKandNovartis. HelmsCM,PolgreenPM.Shouldinfluenzaimmunisation1 bemandatoryforhealthcareworkers?Yes.BMJ 2008;337:a2142.(28October.) IsaacsD,LeaskJ.Shouldinfluenzaimmunisation2 bemandatoryforhealthcareworkers?No.BMJ 2008;337:a2140.(28October.) WorkplaceHealthSafetyAct1995(QLD).s22.www.3 legislation.qld.gov.au/LEGISLTN/CURRENT/W/ WorkplHSaA95.pdf HaywardAC,HarlingR,WettenS,JohnsonAM,Munro4 S,SmedleyJ,etal.Effectivenessofaninfluenzavaccine programmeforcarehomestafftopreventdeath, morbidity,andhealthserviceuseamongresidents: clusterrandomisedcontrolledtrial.BMJ2006;333:1241. Citethisas:BMJ2008;337:a2588 Addressing doctors Scandinavian solution I recently started work in Sweden after a UK medical education and several years working in the NHS. I find the Swedish solution of introductions very appealing: completely do away with titles and address everyone by their first and second names.1 So my badge says “Alison Godbolt, doctor,” and that’s how I introduce myself. Alison K Godbolt specialist trainee in rehabilitation medicine, Uppsala University Hospital, Uppsala, Sweden alison.godbolt@neuro.uu.se Competing interests: None declared. Spence D. You can call me Des.1 BMJ 2008;337:a2328. (29 October.) Citethisas:BMJ2008;337:a2586